RDD Europe 2025 Celebrates 20 Years, Co-Organized by Aptar Pharma and RDD Online
Aptar Pharma, a global leader in respiratory drug delivery solutions, and RDD Online® are proud to announce the co-organization of RDD® Europe 2025, set to take place in-person from Tuesday, May 6 to Friday, May 9, 2025, at the Estoril Congress Center in Estoril, Portugal. This event will mark the 20th anniversary of RDD Europe, one of the largest and most respected international conferences focused on respiratory health.
RDD Europe 2025 is expected to attract over 500 scientists, engineers, clinicians, and business professionals, all dedicated to the advancement of nasal and pulmonary drug delivery. The conference will feature six Knowledge Spaces, each offering curated and peer-reviewed content. These Knowledge Spaces will cover a range of vital topics, with speakers, workshops, poster presentations, and exhibitors sharing actionable insights on the latest advancements in the field.
The primary themes of the Knowledge Spaces will include:
- Bench to Bedside: Emerging Therapies and Clinical Advances
- Inspiring Dry Powder Inhalation: Formulation Science and Device Design
- MDIs in Transition: Evolving Science and Regulations
- Advanced Inhalation: AI and Data-Driven Design
- Aqueous Agenda: Soft Mist Inhalers and Nebulizer Advances
- Nasal Spotlight: Advances in Systemic and Nose-to-Brain Delivery
One of the key highlights of the conference will be the twelve delegate-selectable industry workshops on Wednesday, May 7. These workshops will provide practical, interactive demonstrations of innovative technologies, products, and capabilities in small group settings, offering hands-on experiences with the latest advancements in respiratory drug delivery.
In addition to the Knowledge Spaces and workshops, the conference will feature an integrated Poster & Exhibition session running throughout the three-day event. This will provide ample networking opportunities, with 70 exhibit tables and 72 poster presentations showcasing the latest academic and industry research and breakthroughs in both established and emerging nasal and pulmonary drug delivery platforms.
To enhance the accessibility of the conference, RDD Europe 2025 will also offer extended online access from April 29 to June 30, 2025, providing delegates with on-demand presentations and company profiles. Furthermore, nearly 3,000 peer-reviewed speaker and poster papers will be available for delegates to access for up to 12 months after the conference, ensuring ongoing learning and engagement.
The event will kick off with a Welcome Cocktail Reception on the evening of Tuesday, May 6, followed by a Gala Dinner sponsored by Aptar Pharma on Thursday, May 8, at a scenic location in Estoril.
Aptar Pharma, a leading name in OINDP (Oral Inhalation and Nasal Drug Delivery) device design and technology, is honored to serve as a co-organizer of RDD Europe 2025. The company will also host a workshop on May 7, titled “Ready for Clinical Trials in 1 Hour: A Roadmap to Success.” This workshop will be co-presented by Jonathan Mulpas, Director of Business Development for the Pulmonary Category at Aptar Pharma, Will Ganley, Manager of Computational Pharmaceutics at Nanopharm, an Aptar Pharma company, and Carolina Dantas, Head of Medical & Scientific Affairs at Pulmotree.
“This year’s RDD Europe will be special, not only because it celebrates 20 years of the conference but also because of the location in Estoril. I look forward to reconnecting with friends and colleagues who have attended since the first RDD Europe held in Paris in 2005,” said Richard Dalby, one of the conference organizers. “It’s been incredible to witness the innovations in this field, many of which will directly impact patient health, healthcare provider decision-making, and environmental sustainability.”
Carolyn Penot, Director of Operational Marketing at Aptar Pharma, added, “RDD Europe 2025 is an essential event for anyone involved in nasal and pulmonary drug delivery. The conference will showcase the latest thinking and innovations in the field, and we are excited to celebrate the 20th anniversary with our fellow participants.”
Delegates can register for the event and learn more about sponsorship opportunities through the official RDD Europe 2025 website.
About RDD Online
RDD Online manages and organizes Respiratory Drug Delivery conferences in the U.S. and partners with Aptar Pharma to run RDD events in Europe and Asia. These international conferences focus on technologies and solutions aimed at improving patient health and routinely attract over 500 delegates from more than 25 countries, representing academia, industry, and regulatory agencies. In addition to organizing events, RDD Online offers realistic mouth-throat models, Nephele mixing inlets, dose collection tubes, scientific and technical publications, web-based training, and a company directory for organizations active in pulmonary and nasal drug delivery.
